scholarly article | Q13442814 |
P2093 | author name string | K Ozawa | |
A T Look | |||
T Inaba | |||
T Inukai | |||
T Shinjyo | |||
T Kinoshita | |||
A Miyajima | |||
H Hosoi | |||
P J Houghton | |||
R Kuribara | |||
P2860 | cites work | Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia | Q24293329 |
The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF | Q24522770 | ||
Bim: a novel member of the Bcl-2 family that promotes apoptosis | Q24532974 | ||
Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling | Q24564337 | ||
Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes | Q24564951 | ||
DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein | Q24612650 | ||
I kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domain | Q24643936 | ||
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 | ||
Testicular degeneration in Bclw-deficient mice | Q28116549 | ||
BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members | Q28118771 | ||
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity | Q28138855 | ||
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction | Q28140805 | ||
The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex | Q28141249 | ||
Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt | Q28255373 | ||
Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia | Q28263998 | ||
The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9 | Q28272159 | ||
PIN: an associated protein inhibitor of neuronal nitric oxide synthase | Q28293334 | ||
Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) | Q28297419 | ||
Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue | Q28367688 | ||
Brain cytoplasmic and flagellar outer arm dyneins share a highly conserved Mr 8,000 light chain | Q28507713 | ||
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis | Q28511080 | ||
Regulation of neuronal survival by the serine-threonine protein kinase Akt | Q29614185 | ||
The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
Cytokine signaling for proliferation, survival, and death in hematopoietic cells. | Q33604963 | ||
Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts | Q33651661 | ||
Two distinct interleukin-3-mediated signal pathways, Ras-NFIL3 (E4BP4) and Bcl-xL, regulate the survival of murine pro-B lymphocytes | Q33957711 | ||
Ras effectors and their role in mitogenesis and oncogenesis | Q34439160 | ||
BCL-2 family: regulators of cell death | Q34468840 | ||
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies | Q35207960 | ||
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase | Q36103541 | ||
Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation | Q36490362 | ||
E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. | Q36551510 | ||
Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis | Q36555271 | ||
Interleukin 3-dependent survival by the Akt protein kinase | Q36593239 | ||
Applications of retrovirus-mediated expression cloning | Q36800196 | ||
Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors | Q40805496 | ||
IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line | Q40937398 | ||
Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines | Q40938630 | ||
Cytokine-induced protein kinase B activation and Bad phosphorylation do not correlate with cell survival of hemopoietic cells. | Q40950568 | ||
Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). | Q40952547 | ||
In bone marrow derived Baf-3 cells, inhibition of apoptosis by IL-3 is mediated by two independent pathways. | Q41132557 | ||
The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway | Q41144586 | ||
Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor | Q41175980 | ||
Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line, BaF3. | Q41270140 | ||
Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells | Q41337582 | ||
Inhibition of p21ras activation blocks proliferation but not differentiation of interleukin-3-dependent myeloid cells | Q41436505 | ||
Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. | Q54104607 | ||
Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells | Q57895767 | ||
Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor | Q72121269 | ||
CBFbeta-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents | Q77620598 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 854-864 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors | |
P478 | volume | 21 |